Overview
Bacterial zoonosis acquired through contaminated water or soil. A leading cause of illness after floods and in adventure travelers. Treatable with antibiotics if caught early.
Symptoms
Symptoms | Frequency | Severity | Onset |
|---|---|---|---|
| Conjunctivitis | 40% | Mild | Early |
| Chills | 70% | Mild | Early |
| Fever | 97% | Moderate | Early |
| Headache | 98% | Moderate | Early |
| High fever | 75% | Moderate | Early |
| Myalgia | 90% | Moderate | Early |
| Back pain | 50% | Mild | Early |
| Loss of appetite | 65% | Mild | Early |
| Malaise | 65% | Mild | Early |
| Nausea | 60% | Mild | Early |
| Retro-orbital pain | 35% | Mild | Early |
| Vomiting | 50% | Mild | Early |
| Rash | 10% | Mild | Early |
| Jaundice | 10% | Severe | Peak |
| Oliguria | 15% | Severe | Peak |
| Dark urine | 12% | Moderate | Peak |
| Hemoptysis | 3% | Critical | Peak |
| Hemorrhage | 5% | Severe | Peak |
| Hepatomegaly | 25% | Mild | Peak |
| Hypotension | 8% | Severe | Peak |
| Shortness of breath | 8% | Severe | Peak |
| Petechiae | 8% | Mild | Peak |
| Splenomegaly | 15% | Mild | Peak |
| Abdominal pain | 40% | Mild | Any phase |
| Cough | 25% | Mild | Any phase |
| Diarrhea | 30% | Mild | Any phase |
| Tachycardia | 30% | Mild | Any phase |
Transmission
Overview
Leptospirosis is an acute bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira, with over 300 serovars identified across more than 20 pathogenic species. It is considered the most widespread zoonotic disease in the world, affecting both tropical and temperate regions.
The bacteria are maintained in the renal tubules of chronically infected reservoir animals, particularly rats and other rodents, but also dogs, cattle, pigs, and horses. Leptospira organisms are shed in animal urine and can survive for weeks to months in warm, moist environments. Humans acquire infection through contact of mucous membranes or abraded skin with contaminated water, soil, or animal urine.
Leptospirosis has a remarkably broad clinical spectrum. The majority of infections are subclinical or cause a mild, self-limiting febrile illness. However, 5-15% of symptomatic patients develop severe disease, known as Weil disease (icteric leptospirosis), characterized by jaundice, renal failure, and hemorrhage, with a case fatality rate of 5-15%. Severe pulmonary hemorrhage syndrome (SPHS), an increasingly recognized complication, has a CFR exceeding 50%.
The global burden is estimated at approximately 1 million cases and 58,900 deaths annually (GBD 2015), making leptospirosis one of the leading causes of death among zoonotic diseases. The disease disproportionately affects tropical low-income countries and is increasingly recognized as a significant cause of acute febrile illness in travelers returning from endemic areas.
Overview
Clinical Overview
Leptospirosis is a neglected tropical disease with global distribution, significant morbidity and mortality, and growing relevance for travelers and urban populations in tropical settings.
Key Clinical Facts:
-
Causative agent: Pathogenic Leptospira species (>300 serovars; L. interrogans most common)
-
Transmission: Contact with water, soil, or mud contaminated with infected animal urine; direct animal contact; occupational and recreational exposure
-
Reservoir: Rats (primary), dogs, cattle, pigs, horses, wildlife
-
Incubation period: 2-30 days (typically 7-12 days)
-
Clinical spectrum: Subclinical (majority) → mild anicteric leptospirosis → severe Weil disease → SPHS
-
Case fatality rate: <5% overall; 5-15% for Weil disease; >50% for severe pulmonary hemorrhage syndrome
-
Treatment: Doxycycline (mild), IV penicillin or ceftriaxone (severe)
-
Global burden: ~1 million cases/year, ~58,900 deaths/year
Characteristic Biphasic Course: Leptospirosis classically follows a biphasic pattern:
- Leptospiremic (acute) phase: 3-7 days of fever, headache, myalgia, conjunctival suffusion
- Immune phase: After brief defervescence, fever returns with potential organ-specific complications (meningitis, hepatitis, nephritis)
Risk Groups:
-
Agricultural workers (rice paddies, sugarcane fields, livestock)
-
Sewage and sanitation workers
-
Military personnel deployed to tropical environments
-
Adventure travelers (white-water rafting, caving, jungle trekking)
-
Urban slum populations in tropical cities during flooding
-
Competitors in freshwater sports events (triathlon, eco-challenge races)
Emergency Signs
Emergency Warning Signs
Leptospirosis can progress rapidly to life-threatening Weil disease or severe pulmonary hemorrhage syndrome. Seek immediate emergency care if any of the following develop during or after a febrile illness with potential leptospirosis exposure:
Pulmonary Emergency (Highest Urgency):
-
Hemoptysis (coughing up blood) — may indicate severe pulmonary hemorrhage syndrome (CFR >50%)
-
Acute onset dyspnea with bilateral infiltrates
-
Rapidly progressive respiratory failure
-
Any cough with bloodstained sputum in a patient with suspected leptospirosis
Hepatorenal Emergency:
-
Jaundice (yellow skin and eyes) — indicates hepatic involvement and Weil disease
-
Decreased or absent urine output (oliguria/anuria) — renal failure
-
Dark (cola-colored) urine — may indicate renal involvement or rhabdomyolysis
-
Severe abdominal pain with hepatomegaly and tenderness
-
Peripheral edema and signs of fluid overload
Hemorrhagic Signs:
-
Bleeding from gums, nose, or injection sites
-
Petechiae, purpura, or ecchymoses
-
Blood in stool (melena, hematochezia) or vomit (hematemesis)
Cardiovascular Signs:
-
Chest pain, palpitations, or irregular heartbeat (myocarditis, arrhythmia)
-
Hypotension despite fluid intake
-
Signs of circulatory shock (cold extremities, rapid pulse, altered consciousness)
Neurological Signs:
-
Severe headache with neck stiffness (meningitis)
-
Confusion, altered mental status
-
Seizures
Clinical Context: These signs are particularly concerning if the patient has recently:
-
Been exposed to floodwaters, freshwater bodies, or contaminated soil in tropical areas
-
Participated in water sports, adventure activities, or agricultural work
-
Had contact with animals (especially rodents) or their urine
Detailed Symptoms
Most common signs and symptoms
Symptom Presentation
Leptospirosis presents with a broad clinical spectrum, from asymptomatic infection to fatal multi-organ failure. The classic presentation is a biphasic illness, though in severe cases the phases may merge.
Anicteric Leptospirosis (85-90% of symptomatic cases):
Phase 1 — Leptospiremic/Acute Phase (Days 1-7):
-
Abrupt onset of high fever (38-40°C), often with rigors
-
Severe headache — often frontal, retro-orbital, intense and unremitting
-
Myalgia — characteristically severe in the calves and lumbar region (highly suggestive of leptospirosis)
-
Conjunctival suffusion (bilateral conjunctival redness without exudate) — a distinctive early finding, present in 30-40% of cases
-
Nausea, vomiting, diarrhea, and abdominal pain
-
Non-productive cough in ~25% of patients
-
Hepatosplenomegaly in some cases
-
Transient maculopapular rash (rare)
Phase 2 — Immune Phase (Days 7-14):
-
After brief defervescence (1-3 days), fever recurs
-
Aseptic meningitis in up to 25% (headache, photophobia, neck stiffness; CSF lymphocytosis)
-
Uveitis (may be delayed weeks to months post-infection)
-
Rash
-
Most patients recover during this phase over 1-2 weeks
Severe Leptospirosis / Weil Disease (5-15% of symptomatic cases):
-
Jaundice: Deep icterus from hepatocellular dysfunction and cholestasis (bilirubin often >15 mg/dL)
-
Acute kidney injury: Oliguric or non-oliguric renal failure, characteristic hypokalemic nephropathy
-
Hemorrhage: Pulmonary hemorrhage, epistaxis, GI bleeding, petechiae, ecchymoses
-
Thrombocytopenia
-
Cardiovascular: Myocarditis, arrhythmias, hemodynamic instability
-
Phases tend to merge in severe disease without a clear biphasic pattern
Severe Pulmonary Hemorrhage Syndrome (SPHS):
-
Diffuse alveolar hemorrhage with hemoptysis, dyspnea, and respiratory failure
-
Can occur with or without jaundice/renal failure
-
Chest X-ray shows bilateral diffuse alveolar infiltrates
-
CFR >50%, often fatal within 72 hours of respiratory symptom onset
Knowing the symptoms is the first step to a quick response.
Course of Disease
Disease Course and Progression
Leptospirosis classically follows a biphasic course, though this pattern is most apparent in mild-moderate disease. In severe cases, the phases may overlap or merge.
Exposure (Day 0):
-
Leptospira organisms penetrate intact mucous membranes (conjunctivae, oral, nasal) or abraded skin
-
Common exposure: wading in floodwaters, swimming in contaminated freshwater, contact with animal urine or contaminated soil
-
The organism enters the bloodstream rapidly, within minutes to hours
Incubation Period (Days 2-30, typically 7-12):
-
Spirochetes disseminate hematogenously to multiple organs (liver, kidneys, lungs, meninges, muscles)
-
Replication occurs in target organs and bloodstream
-
Patient is asymptomatic
Phase 1 — Leptospiremic/Septicemic Phase (Days 3-7 of illness):
-
Abrupt onset of high fever, chills, severe headache
-
Intense myalgia (calves, lumbar area — pathognomonic)
-
Conjunctival suffusion (30-40%) — a key clinical clue
-
Nausea, vomiting, abdominal pain
-
Leptospira present in blood and CSF; blood cultures positive
-
Resolves with brief defervescence (1-3 days)
Phase 2 — Immune Phase (Days 7-14 and beyond):
-
Coincides with development of IgM antibodies
-
Fever may recur (lower grade)
-
Aseptic meningitis (up to 25% of cases)
-
Organisms cleared from blood but may persist in kidneys, eyes, and brain
-
Uveitis may develop (sometimes weeks to months later)
-
Most patients recover fully during this phase
Severe Disease Progression (Weil Disease):
-
In 5-15% of symptomatic patients, disease progresses rapidly without a clear biphasic pattern
-
Days 4-7: Progressive jaundice, oliguric renal failure, hemorrhagic manifestations
-
Days 7-14: Peak organ dysfunction; ICU care required. Renal failure, hepatorenal syndrome, DIC.
-
If SPHS develops: Acute respiratory deterioration with diffuse alveolar hemorrhage, typically days 4-10 of illness. Can be fulminant.
Recovery:
-
Mild disease: 1-3 weeks to full recovery
-
Weil disease: 3-6 weeks of convalescence; renal function typically recovers
-
Urine shedding of Leptospira may continue for weeks to months
Diagnosis
How this disease is identified
Diagnosis
Leptospirosis diagnosis is challenging because early symptoms mimic many other febrile illnesses. A high index of clinical suspicion based on epidemiological exposure is essential. Empiric treatment should not be delayed pending laboratory confirmation.
Clinical Clues: The combination of acute fever + severe myalgia (especially calves) + conjunctival suffusion + history of water/animal exposure is highly suggestive. Jaundice with acute kidney injury and hemorrhage (Weil disease) in a person with appropriate exposure should prompt immediate treatment.
Laboratory Diagnostic Methods:
-
Microscopic Agglutination Test (MAT) — Gold Standard:
- Tests patient serum against a panel of live Leptospira serovars
- 4-fold rise between acute and convalescent sera (2-4 weeks apart) is diagnostic
- Single titer >=1:800 in an endemic area with compatible symptoms is presumptive
- Identifies infecting serogroup
- Requires live culture maintenance — available only at reference laboratories
- Sensitivity limited in early disease (antibodies develop 5-10 days post-onset)
-
IgM ELISA:
- Commercially available rapid tests
- Detectable from approximately day 5-7 of illness
- Sensitivity: 52-97% (varies by test and timing); Specificity: 85-97%
- Suitable for point-of-care diagnosis in endemic settings
- False negatives common in the first week
-
PCR (Polymerase Chain Reaction):
- Detects leptospiral DNA in blood (first 7-10 days) and urine (after first week)
- Highly specific; sensitivity 50-80% depending on timing and specimen
- Useful for early diagnosis before antibodies develop
- Increasingly available in reference and hospital laboratories
-
Culture:
- Blood or CSF culture in EMJH medium during the first 7-10 days; urine culture after first week
- Slow growth: 1-13 weeks (often 2-4 weeks)
- Highly specific but low sensitivity; impractical for clinical decision-making
-
Dark-Field Microscopy:
- Direct visualization of spirochetes in blood or urine
- Very low sensitivity and specificity; not recommended as sole diagnostic method
Supporting Laboratory Findings:
-
Mild to moderate leukocytosis (often with left shift)
-
Thrombocytopenia (common in severe disease)
-
Elevated creatinine, BUN (renal involvement — characteristically with hypokalemia)
-
Elevated bilirubin and transaminases (hepatic involvement; AST/ALT typically <200 U/L, bilirubin often disproportionately high)
-
Elevated CK (rhabdomyolysis)
-
CSF: lymphocytic pleocytosis with normal glucose (aseptic meningitis pattern)
Treatment
Available treatment methods
Treatment and Management
Antibiotic treatment is recommended for all confirmed or suspected leptospirosis cases, ideally initiated early in the disease course. Supportive care is critical for severe disease.
Mild Disease (Anicteric Leptospirosis):
-
Doxycycline 100 mg PO twice daily for 7 days — first-line oral therapy
-
Azithromycin 500 mg PO daily for 3 days — alternative (pregnancy-safe option)
-
Amoxicillin 500 mg PO three times daily for 7 days — alternative
-
Supportive care: hydration, antipyretics (paracetamol), rest
-
Avoid NSAIDs due to renal and bleeding risks
-
Monitor for progression to severe disease, especially during the first week
Severe Disease (Weil Disease, SPHS):
-
IV Penicillin G 1.5 million units IV every 6 hours — traditional first-line for severe disease
-
IV Ceftriaxone 1g IV once daily — preferred by many clinicians for convenience and broad coverage; equally effective
-
IV Cefotaxime 1g IV every 6 hours — alternative
-
Duration: 7 days (minimum)
Note on Jarisch-Herxheimer Reaction:
-
Can occur within hours of initiating antibiotic therapy (due to rapid leptospiral lysis)
-
Presents with fever spike, rigors, hypotension, and tachycardia
-
Generally self-limiting; manage with supportive care
-
Does not necessitate stopping antibiotics
Supportive Care for Severe Disease:
-
Fluid management: Careful IV fluid resuscitation; avoid fluid overload in patients with renal failure and pulmonary hemorrhage
-
Renal replacement therapy: Hemodialysis or CRRT for severe acute kidney injury (recovery expected in most survivors)
-
Mechanical ventilation: For SPHS and respiratory failure; lung-protective ventilation strategies
-
Blood products: Platelet transfusion for severe thrombocytopenia; packed RBCs for hemorrhage
-
Vasopressors: For refractory hypotension
-
Cardiac monitoring: For patients with myocarditis or arrhythmias
Chemoprophylaxis:
-
Doxycycline 200 mg PO once weekly has been used for short-term prophylaxis in high-risk settings (military, adventure races, flood response)
-
Evidence for efficacy is mixed; a meta-analysis showed ~50% reduction in clinical disease
-
Not routinely recommended for all travelers but may be considered for specific high-risk exposures
Most cases are effectively treated with early diagnosis.
Prevention Details
How to protect yourself
Prevention Strategies
No universally available human vaccine exists for leptospirosis. Prevention focuses on reducing exposure to contaminated water and animals, environmental management, and targeted chemoprophylaxis.
Personal Protective Measures:
-
Avoid contact with potentially contaminated water: Do not wade, swim, or kayak in freshwater bodies (ponds, rivers, flooded areas) in endemic regions, especially after heavy rain
-
Cover cuts and abrasions: Use waterproof dressings on all skin wounds before potential exposure
-
Wear protective footwear: Boots (preferably rubber) when walking through wet areas, farmland, or floodwaters
-
Wear gloves and protective clothing when handling animals, animal tissues, or cleaning animal housing
-
Practice good hygiene: Wash hands thoroughly after animal contact; shower after freshwater exposure in endemic areas
-
Do not drink untreated freshwater from potentially contaminated sources
Occupational Prevention:
-
Rodent control in workplaces (farms, warehouses, sewers, markets)
-
PPE for high-risk workers: Waterproof boots, gloves, goggles, and face shields for sewage workers, farmers, and abattoir workers
-
Veterinary measures: Livestock vaccination (where available), drainage of waterlogged fields, livestock housing hygiene
Environmental and Community Measures:
-
Rodent control programs: Reduce the primary reservoir in urban and periurban areas
-
Flood preparedness: Rapid drainage, public advisories against contact with floodwater
-
Sanitation: Proper waste disposal and sewage management
-
Education: Community awareness campaigns in endemic areas, particularly before rainy seasons
Vaccination:
-
Human vaccines exist but have limited availability: Inactivated whole-cell vaccines are licensed in some countries (Cuba, China, France, Japan)
-
These vaccines are serovar-specific and do not provide cross-protection against all serovars
-
Duration of immunity is limited (requires annual boosters)
-
Not widely recommended for travelers
-
Newer subunit and conjugate vaccines are in development
Chemoprophylaxis:
-
Doxycycline 200 mg PO once weekly — used for short-term prophylaxis during high-risk exposure
-
Evidence: One RCT (Takafuji 1984) showed 95% reduction in military setting; subsequent meta-analysis (Brett-Major 2009) showed ~50% overall efficacy — results vary by setting
-
Recommended by some experts for: military deployments, flood response workers, adventure sports participants in highly endemic areas
-
Duration: start before exposure, continue through exposure period and 1 week after
-
Not routinely recommended for all travelers
Preparation is the best protection.
Travel Advice
Travel Advice
Leptospirosis is an increasingly recognized cause of febrile illness in travelers returning from tropical destinations, particularly those involved in freshwater activities.
High-Risk Destinations:
-
Southeast Asia: Thailand, Philippines, Indonesia, Malaysia, Vietnam, Laos, Cambodia — leading destinations for travel-associated leptospirosis
-
South Asia: India (particularly during monsoon season), Sri Lanka, Bangladesh, Nepal
-
Central and South America: Brazil, Peru, Costa Rica, Nicaragua, Haiti, Colombia
-
Pacific Islands: Hawaii, Fiji, Samoa, Palau
-
Africa: Sub-Saharan tropical countries, particularly during floods
-
Caribbean: Trinidad, Jamaica, Barbados
High-Risk Activities:
-
White-water rafting, kayaking, canoeing
-
Canyoning, caving (spelunking)
-
Freshwater swimming (rivers, lakes, waterfalls) in endemic areas
-
Jungle trekking through wet terrain
-
Eco-challenge and adventure races (historically linked to outbreaks)
-
Rice paddy agriculture or farm visits
-
Volunteer work in flood-affected or slum areas
Pre-Travel Recommendations:
- Consult a travel medicine provider, especially if planning freshwater or adventure activities
- Wound care supplies: Carry waterproof bandages to cover all skin abrasions
- Footwear: Bring waterproof boots for wet environments
- Chemoprophylaxis: Discuss weekly doxycycline prophylaxis with your provider if planning high-risk activities (e.g., multiday rafting, agricultural work, flood response)
- Know the symptoms to enable early self-referral
During Travel:
-
Minimize contact with freshwater in endemic areas, especially after rain
-
Cover all wounds with waterproof dressings before freshwater exposure
-
Wear protective footwear in wet environments
-
Shower promptly after freshwater exposure
-
Avoid swallowing freshwater while swimming or during water sports
Post-Travel:
-
Seek medical attention if fever, severe headache, myalgia (especially calf pain), or jaundice develops within 2-30 days of return
-
Inform clinicians of specific water and animal exposures during travel
-
Mention leptospirosis specifically, as it is frequently not considered in the initial differential
-
Early antibiotic treatment significantly improves outcomes
How common is it?
Statistics and geographic data
Epidemiology
Leptospirosis is the most widespread zoonotic disease globally, with a disproportionately high burden in tropical low-income settings.
Global Burden:
-
Estimated 1.03 million cases and 58,900 deaths annually (Global Burden of Disease, 2015)
-
Highest incidence in tropical and subtropical regions, particularly in South and Southeast Asia, Central and South America, and Oceania
-
Significantly underreported due to nonspecific symptoms, lack of diagnostic capacity, and low clinical awareness
-
DALYs lost estimated at 2.9 million annually — comparable to or exceeding many higher-profile NTDs
Incidence Rates:
-
Tropical regions: 10-100+ per 100,000/year (higher during outbreaks)
-
Temperate regions: 0.1-1 per 100,000/year
-
Urban slums in tropical cities during floods: attack rates can reach 100-500 per 100,000
-
Outbreak-associated incidence may far exceed baseline
Notable Outbreaks:
-
Philippines (annually): 500-3,000 reported cases per year; major floods (e.g., Typhoon Ondoy 2009) cause large epidemics
-
Brazil: Major urban outbreaks in Sao Paulo, Rio de Janeiro, and Salvador during rainy seasons; >3,000 cases reported annually
-
India: Monsoon-associated outbreaks in Mumbai, Kerala, Gujarat; estimated >5,000 cases/year
-
Sri Lanka: Endemic with seasonal peaks; 5,000-7,000 cases/year
-
International sporting events: Springfield, Illinois Triathlon (1998), Eco-Challenge Borneo (2000), Dusi Canoe Marathon South Africa (multiple years)
Transmission Ecology:
-
Leptospira excreted in urine of reservoir animals (rats, dogs, cattle, pigs)
-
Organisms survive for weeks in warm (>20°C), moist, neutral-alkaline environments
-
Humans are incidental hosts; human-to-human transmission is extremely rare
-
Seasonal peaks coincide with rainy seasons and monsoons
-
Climate change (increased flooding frequency and intensity) is expected to increase global burden
Demographic Distribution:
-
Male-to-female ratio: 3-4:1 (largely occupational bias)
-
Highest incidence in working-age adults (20-49 years)
-
Children in endemic areas are also at significant risk (waterplay, bare feet)
-
Increasingly recognized in urban populations (not just rural/agricultural)
Risk Factors
Who is most at risk
Risk Factors
Risk factors for leptospirosis relate to exposure to contaminated water or animals, and host factors that influence disease severity.
Environmental and Exposure Risk Factors:
-
Flooding: The single most important risk factor globally. Urban flooding in tropical cities drives epidemic leptospirosis (e.g., Mumbai floods, Manila floods, Brazilian urban outbreaks).
-
Freshwater exposure: Swimming, wading, rafting in potentially contaminated rivers, lakes, and streams
-
Occupational exposure:
- Rice paddy farmers (prolonged standing water exposure)
- Sugarcane workers
- Sewage and sanitation workers
- Abattoir workers and butchers
- Veterinarians
- Military personnel (jungle training, deployments)
- Miners
-
Urban slum residence: Poor sanitation, proximity to rats, flooding
-
Animal contact: Rats (primary reservoir), dogs, cattle, pigs, horses
-
Recreational exposure: Adventure sports, triathlon, eco-challenge events in endemic areas
-
Rainy/monsoon season: Highest incidence during and after heavy rains
Risk Factors for Severe Disease (Weil Disease/SPHS):
-
Delay in antibiotic treatment — the most modifiable risk factor
-
Age >40 years — associated with higher mortality
-
Male sex — higher incidence (occupational bias) and possibly more severe disease
-
High initial leptospiral burden — related to intensity and duration of exposure
-
Certain serovars: L. interrogans serovar Icterohaemorrhagiae and Copenhageni are associated with more severe disease
-
Pre-existing liver disease (alcohol-related hepatitis, chronic hepatitis B/C)
-
Chronic kidney disease
-
Immunosuppression
-
Thrombocytopenia at presentation — predictor of severe outcome
Protective Factors:
-
Use of protective clothing and footwear in wet environments
-
Rodent control in and around dwellings
-
Prompt antibiotic treatment upon symptom onset
-
Previous infection provides serovar-specific immunity (but not cross-serovar)
-
Avoidance of freshwater exposure in endemic areas during flooding events
Complications Details
Potential complications
Complications
Leptospirosis complications arise from immune-mediated organ damage and direct leptospiral toxicity, primarily affecting the kidneys, liver, lungs, and eyes.
Renal Complications:
-
Acute kidney injury (AKI): The hallmark of severe leptospirosis. Occurs in 40-60% of Weil disease cases. Characteristically non-oliguric and hypokalemic (distinguishing it from most other causes of AKI). Mechanism involves interstitial nephritis and proximal tubular dysfunction. Most patients who survive recover renal function, though dialysis may be required during the acute phase.
-
Chronic kidney disease: Uncommon but may follow severe AKI, particularly with delayed treatment or recurrent episodes.
Hepatic Complications:
-
Icteric hepatitis: Cholestatic jaundice with elevated conjugated bilirubin (often >15 mg/dL). Unlike viral hepatitis, transaminases are usually only mildly elevated (<200 U/L) — a useful differentiating feature. Hepatocellular necrosis is generally mild; liver failure is uncommon.
-
Hepatorenal syndrome: Combined liver and kidney failure carries a worse prognosis.
Pulmonary Complications:
-
Severe pulmonary hemorrhage syndrome (SPHS): The most feared complication. Diffuse alveolar hemorrhage with hemoptysis, respiratory failure, and bilateral pulmonary infiltrates. CFR >50%. Incidence is increasing in recent decades. May occur without jaundice, making diagnosis difficult.
-
ARDS: Acute respiratory distress syndrome may develop with or without alveolar hemorrhage.
Cardiac Complications:
-
Myocarditis: Presents with chest pain, arrhythmias (atrial fibrillation, ventricular tachycardia), and heart failure
-
Conduction abnormalities: PR prolongation, bundle branch block, ST-T changes
-
Hemodynamic instability: Myocardial depression contributing to shock
Ocular Complications:
-
Leptospiral uveitis: May develop 2 weeks to 2 years after acute infection. Presents with eye pain, photophobia, blurred vision. Can be bilateral and recurrent. Responds to topical corticosteroids.
-
Endophthalmitis: Rare but severe
Hemorrhagic Complications:
-
DIC: With consumption of clotting factors and platelets
-
Gastrointestinal hemorrhage: Hematemesis, melena
-
Subarachnoid hemorrhage: Rare but reported
Other Complications:
-
Rhabdomyolysis: Elevated CK, myoglobinuria contributing to AKI
-
Pancreatitis: Uncommon but documented
-
Guillain-Barre syndrome: Rare post-infectious complication
-
Persistent fatigue and post-leptospirosis syndrome: Prolonged malaise, headaches, and depression lasting months
Recovery & Outlook
Expected outcomes and recovery
Prognosis and Outcomes
Prognosis varies enormously across the clinical spectrum of leptospirosis, from full recovery in mild cases to high mortality in severe pulmonary and hepatorenal disease.
Mild/Anicteric Leptospirosis:
-
Excellent prognosis with full recovery expected
-
Self-limiting in most cases, even without antibiotic treatment
-
Duration: 1-3 weeks
-
Antibiotic treatment shortens illness duration and reduces complications
-
Residual fatigue and myalgia may persist for weeks
Weil Disease (Icteric Leptospirosis):
-
Case fatality rate: 5-15% with appropriate treatment
-
CFR rises to 20-40% in settings with limited ICU resources
-
Acute kidney injury is usually reversible — most survivors recover renal function fully within weeks
-
Jaundice resolves over 2-4 weeks after clinical improvement
-
Key prognostic factors: age, delay to treatment, degree of renal impairment, thrombocytopenia
Severe Pulmonary Hemorrhage Syndrome:
-
CFR exceeds 50%, even with ICU care
-
Rapid onset and progression — death may occur within 72 hours of respiratory symptom onset
-
Early intubation and mechanical ventilation may improve outcomes
-
Survivors generally recover pulmonary function
Predictors of Poor Outcome:
-
Altered mental status or coma at presentation
-
Oliguria or anuria
-
Pulmonary hemorrhage or ARDS
-
Serum creatinine >3 mg/dL
-
Serum bilirubin >10 mg/dL
-
Thrombocytopenia (<70,000/uL)
-
Age >40 years
-
Delay in antibiotic initiation >4 days from symptom onset
Long-Term Sequelae:
-
Chronic uveitis: May develop weeks to months after acute infection; responds to topical steroids
-
Chronic kidney disease: Uncommon but reported after severe AKI
-
Chronic fatigue and depression: Reported in a subset of survivors
-
Recurrent headaches and myalgia: May persist for months
-
Immunity to the infecting serovar develops but does not protect against other serovars (reinfection with different serovars is possible)